![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 3, 1399-1402, January 17, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Molecular Medicine Laboratory and Macromolecular
Crystallography Unit, Division of Experimental Medicine, Harvard
Institutes of Medicine, Harvard Medical School,
Boston, Massachusetts 02115
Erbin contains a class I PDZ domain that binds to
the C-terminal region of the receptor tyrosine kinase ErbB2, a class II ligand. The crystal structure of the human Erbin PDZ bound to the
peptide EYLGLDVPV corresponding to the C-terminal residues 1247-1255 of human ErbB2 has been determined at 1.25-Å resolution. The Erbin PDZ deviates from the canonical PDZ fold in that it contains
a single The atomic coordinates and structure factors (codes 1MFG and
1MFL) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New
Brunswick, NJ (http://www.rcsb.org/).
ACCELERATED PUBLICATION
Novel Mode of Ligand Recognition by the Erbin PDZ Domain*
-helix. The isopropyl group of valine at position
2 of
the ErbB2 peptide interacts with the Erbin Val1351
and displaces the peptide backbone away from the
-helix, elucidating the molecular basis of class II ligand recognition by a class I PDZ
domain. Strikingly, the phenolic ring of tyrosine
7 enters into a
pocket formed by the extended
2-
3 loop of the Erbin PDZ. Phosphorylation of tyrosine
7 abolishes this interaction but does not
affect the binding of the four C-terminal peptidic residues to PDZ, as
revealed by the crystal structure of the Erbin PDZ complexed with a
phosphotyrosine-containing ErbB2 peptide. Since phosphorylation of
tyrosine
7 plays a critical role in ErbB2 function, the selective
binding and sequestration of this residue in its unphosphorylated state
by the Erbin PDZ provides a novel mechanism for regulation of the
ErbB2-mediated signaling and oncogenicity.
*
This work was supported by grants from the National
Institutes of Health, the Massachusetts Department of Public Health,
and the United States Department of Defense (to J. A. A. L.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Established Investigator of the American Heart Association. To
whom correspondence should be addressed: Molecular Medicine Laboratory,
Harvard Institutes of Medicine, Rm. 354, 4 Blackfan Circle, Boston, MA
02115. E-mail: jladias@caregroup.harvard.edu.
This article has been cited by other articles:
![]() |
J. Liu, J. Zhang, Y. Yang, H. Huang, W. Shen, Q. Hu, X. Wang, J. Wu, and Y. Shi Conformational change upon ligand binding and dynamics of the PDZ domain from leukemia-associated Rho guanine nucleotide exchange factor Protein Sci., June 1, 2008; 17(6): 1003 - 1014. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Stiffler, J. R. Chen, V. P. Grantcharova, Y. Lei, D. Fuchs, J. E. Allen, L. A. Zaslavskaia, and G. MacBeath PDZ Domain Binding Selectivity Is Optimized Across the Mouse Proteome Science, July 20, 2007; 317(5836): 364 - 369. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Chen, X. Niu, Y. Xu, J. Wu, and Y. Shi Solution structure and backbone dynamics of the AF-6 PDZ domain/Bcr peptide complex Protein Sci., June 1, 2007; 16(6): 1053 - 1062. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Lamprecht and U. Seidler The emerging role of PDZ adapter proteins for regulation of intestinal ion transport Am J Physiol Gastrointest Liver Physiol, November 1, 2006; 291(5): G766 - G777. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Appleton, Y. Zhang, P. Wu, J. P. Yin, W. Hunziker, N. J. Skelton, S. S. Sidhu, and C. Wiesmann Comparative Structural Analysis of the Erbin PDZ Domain and the First PDZ Domain of ZO-1: INSIGHTS INTO DETERMINANTS OF PDZ DOMAIN SPECIFICITY J. Biol. Chem., August 4, 2006; 281(31): 22312 - 22320. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Haslekas, K. Breen, K. W. Pedersen, L. E. Johannessen, E. Stang, and I. H. Madshus The Inhibitory Effect of ErbB2 on Epidermal Growth Factor-induced Formation of Clathrin-coated Pits Correlates with Retention of Epidermal Growth Factor Receptor-ErbB2 Oligomeric Complexes at the Plasma Membrane Mol. Biol. Cell, December 1, 2005; 16(12): 5832 - 5842. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Madsen, T. Beuming, M. Y. Niv, C.-w. Chang, K. K. Dev, H. Weinstein, and U. Gether Molecular Determinants for the Complex Binding Specificity of the PDZ Domain in PICK1 J. Biol. Chem., May 27, 2005; 280(21): 20539 - 20548. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Joubert, B. Hanson, G. Barthet, M. Sebben, S. Claeysen, W. Hong, P. Marin, A. Dumuis, and J. Bockaert New sorting nexin (SNX27) and NHERF specifically interact with the 5-HT4(a) receptor splice variant: roles in receptor targeting J. Cell Sci., October 15, 2004; 117(22): 5367 - 5379. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Becamel, S. Gavarini, B. Chanrion, G. Alonso, N. Galeotti, A. Dumuis, J. Bockaert, and P. Marin The Serotonin 5-HT2A and 5-HT2C Receptors Interact with Specific Sets of PDZ Proteins J. Biol. Chem., May 7, 2004; 279(19): 20257 - 20266. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. J. Im, J. H. Lee, S. H. Park, S. J. Park, S.-H. Rho, G. B. Kang, E. Kim, and S. H. Eom Crystal Structure of the Shank PDZ-Ligand Complex Reveals a Class I PDZ Interaction and a Novel PDZ-PDZ Dimerization J. Biol. Chem., November 28, 2003; 278(48): 48099 - 48104. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Nourry, S. G. N. Grant, and J.-P. Borg PDZ Domain Proteins: Plug and Play! Sci. Signal., April 22, 2003; 2003(179): re7 - re7. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |